首页> 美国卫生研究院文献>The Oncologist >Survival Analysis for Patients with ALK Rearrangement‐Positive Non‐Small Cell Lung Cancer and a Poor Performance Status Treated with Alectinib: Updated Results of Lung Oncology Group in Kyushu 1401

【2h】

Survival Analysis for Patients with ALK Rearrangement‐Positive Non‐Small Cell Lung Cancer and a Poor Performance Status Treated with Alectinib: Updated Results of Lung Oncology Group in Kyushu 1401

机译：ALK重排阳性非小细胞肺癌患者的生存率分析并用艾来替尼治疗的病情较差：九州1401年肺癌研究组的最新结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 The Oncologist
作者
Eiji Iwama; Yasushi Goto; Haruyasu Murakami; Shinsuke Tsumura; Hiroyuki Sakashita; Yoshiaki Mori; Noriaki Nakagaki; Yuka Fujita; Masahiro Seike; Akihiro Bessho; Manabu Ono; Masaru Nishitsuji; Hiroaki Akamatsu; Ryotaro Morinaga; Takanori Akagi; Takayuki Shimose; Shoji Tokunaga; Nobuyuki Yamamoto; Yoichi Nakanishi; Kenji Sugio; Isamu Okamoto;
展开▼
作者单位

展开▼
年(卷),期 2020(25),4
年度 2020
页码 -1
总页数 9
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Survival Analysis for Patients with ALK Rearrangement-Positive Non-Small Cell Lung Cancer and a Poor Performance Status Treated with Alectinib: Updated Results of Lung Oncology Group in Kyushu 1401 [J] . Eiji Iwama, Akihiro Bessho, Manabu Ono, The oncologist . 2020,第4期

机译：ALK重排阳性非小细胞肺癌患者的存活分析及邻接治疗的性能状况不佳：九州肺肿瘤学群体的更新结果
2. Alectinib for Patients with ALK Rearrangement–Positive Non–Small Cell Lung Cancer and a Poor Performance Status (Lung Oncology Group in Kyushu?1401) [J] . Eiji Iwama, Yasushi Goto, Haruyasu Murakami, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017,第7期

机译：alectinib用于患有ALK重排阳性非小细胞肺癌的患者及性能状况不佳（九州肺部肿瘤组织？1401）
3. P1.03-004 Alectinib for Patients with ALK Rearrangement–Positive Non–Small Cell Lung Cancer and a Poor Performance Status [J] . H. Kenmotsu, E. Iwama, Y. Goto, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017,第11期

机译：P1.03-004 alectinib适用于ALK重排阳性非小细胞肺癌的患者和绩效状况不佳
4. Enumeration and ALK Investigation of Circulating Tumor Cells in Non-Small Cell Lung Cancer (NSCLC) Patients Using an Effective In Vivo Technology, the GILUPI CellCollector? [C] . Klaus Luecke, Lukasz Gasiorowski, Stefanie Herold, International Molecular Medicine Tri-Conference. . 2015

机译：使用有效的体内技术（Gilupi Cellcollector
5. Treating Very Large Non-Small Cell Lung Cancers: A Survival Analysis using National Cancer Databases [D] . Moreno, Amy Catherine 2014

机译：治疗非常大的非小细胞肺癌：使用国家癌症数据库的生存分析
6. Dramatic response to alectinib in a patient of ALK-rearranged lung cancer with poor performance status [O] . Hisashi Tanaka, Kageaki Taima, Takeshi Morimoto, 2016

机译：ALK重排的肺癌患者对依乐替尼的严重反应
7. Dramatic response to alectinib in a patient of ALK-rearranged lung cancer with poor performance status [O] . 2016

机译：ALK重排的肺癌患者对依乐替尼的严重反应

Survival Analysis for Patients with ALK Rearrangement‐Positive Non‐Small Cell Lung Cancer and a Poor Performance Status Treated with Alectinib: Updated Results of Lung Oncology Group in Kyushu 1401

著录项

相似文献

相关主题

期刊订阅